Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to the United States' request for sensitive information.
This move came to light after a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesman has since clarified that the United States was seeking genetic material for scientific study and commercial purposes but refused to share the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further talks to reach a deal suitable to both sides so the nation's critical HIV treatment initiative can be sustained.
Broader Implications
Zimbabwe's decision comes after a comparable case in Kenya, where a court halted a similar health funding agreement after legal challenges were filed about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump argued its spending was "wasteful" and his administration was seeking direct bilateral deals to boost openness and responsibility.
According to statements, Sixteen African countries have so far agreed to these new health pacts, representing over $18.3bn in new funding.
Details of the Rejected Deal
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, without any equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that could result from that shared data," his statement read.
"Effectively, our country would provide the basic resources for scientific discovery without any certainty that the end products would be available to our population if a future pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its push of one-on-one health agreements were upending structures already set up through the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This mechanism is intended to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We are open to continued dialogue with our American counterparts on how future co-operation could be arranged in a way that respects the sovereignty and interests of each country."
Medical Community Reaction
A leading public health body expressed it understood the official position, but suggested that negotiations should continue considering a large portion of the nation's Aids initiatives depended on international support.
"In cases where specific concerns arise, including those involving information security or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group commented.
The situation highlights the complex debate between receiving vital foreign assistance and protecting national sovereignty in an ever more data-driven world.